Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This refers to the concurrent use of colchicine and paracetamol (acetaminophen). According to the provided information, there are no specific drug interactions found between colchicine and paracetamol. This combination is described as a concurrent medication regimen rather than a single formulated product. The combination may be used in conditions such as gout management, where colchicine addresses inflammation and paracetamol provides pain relief. A study in patients with knee osteoarthritis showed that adding colchicine (1.5 g/day) to paracetamol therapy (3 g/day) for 6 months improved clinical parameters (WOMAC scale) compared to paracetamol alone. Colchicine is an anti-inflammatory medication used for treating acute gout attacks, preventing gout flares, and preventing symptoms of familial Mediterranean fever (FMF). It reduces inflammation, particularly that caused by uric acid crystals. Common side effects include abdominal pain, constipation, diarrhea, nausea, and vomiting. Serious side effects like rhabdomyolysis can occur. Paracetamol is a simple pain reliever used to manage pain and fever.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Colchicine and Paracetamol combination.